日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Covalent Organic Framework-Carbon Nanotube Core-Shell Nanohybrids for Enhanced Catalytic Site Utilization of Molecular Catalysts in CO(2) Electroreduction

共价有机框架-碳纳米管核壳纳米杂化物用于增强分子催化剂在CO₂电还原反应中的催化位点利用率

Yao, Liang; Rodríguez-Camargo, Andrés; Guntermann, Roman; Heck, Fabian; Van Gele, Samuel; Vignolo-González, Hugo; Duppel, Viola; Bein, Thomas; Lotsch, Bettina V

The Devil Is in the Details: Pitfalls and Ambiguities in the Analysis of X-ray Powder Diffraction Data of 2D Covalent Organic Frameworks

细节决定成败:二维共价有机框架X射线粉末衍射数据分析中的陷阱和歧义

Van Gele, Samuel; Bette, Sebastian; Lotsch, Bettina V

Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa

外显子跳跃反义寡核苷酸的个性化开发可恢复交界性大疱性表皮松解症中的 XVII 型胶原表达

Michael Ablinger, Thomas Lettner, Nicole Friedl, Hannah Potocki, Theresa Palmetzhofer, Ulrich Koller, Julia Illmer, Bernadette Liemberger, Stefan Hainzl, Alfred Klausegger, Manuela Reisenberger, Jo Lambert, Mireille Van Gele, Eline Desmet, Els Van Maelsaeke, Monika Wimmer, Roland Zauner, Johann W Ba

Towards the development of a RNAi-based topical treatment for psoriasis: Proof-of-concept in a 3D psoriasis skin model

开发基于 RNAi 的银屑病局部治疗方法:3D 银屑病皮肤模型中的概念验证

Eline Desmet, Mireille Van Gele, Lynda Grine, Katrien Remaut, Jo Lambert

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response

转移性黑色素瘤立体定向放射治疗联合抗PD-1治疗的II期临床试验:临床和免疫反应评估

De Wolf, Katrien; Kruse, Vibeke; Sundahl, Nora; van Gele, Mireille; Chevolet, Ines; Speeckaert, Reinhart; Brochez, Lieve; Ost, Piet

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response

一项针对转移性尿路上皮癌患者的I/II期临床试验,评估固定剂量立体定向放射治疗联合序贯或同步帕博利珠单抗治疗的安全性、临床疗效和免疫学反应。

Sundahl, Nora; De Wolf, Katrien; Rottey, Sylvie; Decaestecker, Karel; De Maeseneer, Daan; Meireson, Annabel; Goetghebeur, Els; Fonteyne, Valérie; Verbeke, Sofie; De Visschere, Pieter; Reynders, Dries; Van Gele, Mireille; Brochez, Lieve; Ost, Piet

JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases

JAK3 作为炎症性皮肤病局部治疗的新兴靶点

Ana Karina Alves de Medeiros, Reinhart Speeckaert, Eline Desmet, Mireille Van Gele, Sofie De Schepper, Jo Lambert

Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma

浆细胞样树突状细胞和髓系抑制细胞在黑色素瘤中的临床意义

Ines Chevolet, Reinhart Speeckaert, Max Schreuer, Bart Neyns, Olga Krysko, Claus Bachert, Mireille Van Gele, Nanja van Geel, Lieve Brochez

Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma

黑色素瘤循环免疫细胞中 IDO、色氨酸代谢、PD-L1 和 CTLA-4 的体内免疫网络特征

I Chevolet, R Speeckaert, M Schreuer, B Neyns, O Krysko, C Bachert, B Hennart, D Allorge, N van Geel, M Van Gele, L Brochez

Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression

鉴定控制黑色素生成和黑色素瘤进展的 ZEB2-MITF-ZEB1 转录网络

G Denecker, N Vandamme, O Akay, D Koludrovic, J Taminau, K Lemeire, A Gheldof, B De Craene, M Van Gele, L Brochez, G M Udupi, M Rafferty, B Balint, W M Gallagher, G Ghanem, D Huylebroeck, J Haigh, J van den Oord, L Larue, I Davidson, J-C Marine, G Berx